Related Experiment Video
Updated: Jun 24, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Genome science of lipid metabolism and obesity
Abstract:
Abnormalities in lipid metabolism cause obesity leading to metabolic syndrome. Thus, improvement of the abnormalities is significant for the treatment of metabolic syndrome. Nuclear receptors activated by specific ligands regulate lipid metabolism at the genomic level. The expression of lipid metabolism-related enzymes is increased or decreased by the activity of various nuclear receptors. The regulation of enzyme expression is mediated by specific response elements to each nuclear receptor in promoters of target genes. Many food factors acting as agonists or antagonists control the activities of nuclear receptors. Here, we provide several examples of food factors acting as agonists or antagonists, which are useful for the management of obesity accompanied by lipid metabolism abnormalities.
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Obesity
Lipid Catabolism
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Pharmacogenomics: Identification of New Drug Targets
Cholesterol: Significance and Regulation
Considering cholesterol and...
